Sun Pharma Slips on $12 Billion Organon Deal Buzz

Shares of Sun Pharmaceutical Industries Limited fell nearly 4% amid reports of a $12 billion bid for Organon & Co.. The company has completed due diligence and is finalising financing, raising investor concerns over the deal size and funding impact.